Tilray Brands Plunged 17% Yesterday - Here's Why

Image source


Tilray (TLRY) stock plunged yesterday, July 29, following a brutal fiscal Q4 earnings report that reinforced concerns about Tilray’s strategic direction and financial health spooking investors. 

Below is what, specifically, triggered the drop:

  • Reported Staggering Q4 Net Loss: The company reported a staggering quarterly loss, driven by a $1.4 billion non-cash impairment charge tied to its 2021 acquisitions during the Aphria merger.
  • Q4 Revenue Came In Below Analyst Expectations:
    • Cannabis Segment Revenue Declined: Revenue dropped due to halted product lines and international permit delays.
    • Beverage Segment Revenue Fell: Revenue fell impacted by restructuring under “Project 420” and product rationalization.

Tilray's stock dropped 17% yesterday while the 4 other constituents in the Canadian Cannabis LP Stocks Portfolio reacted negatively to Tilray's Q4 results yesterday, July 29th, as follow, in ascending order, with any specific catalyst that contributed to the decline :

  1. Tilray Brands (TLRY) DOWN 17.1% 
    • Catalyst: As above
  2. Aurora Cannabis (ACB): DOWN 7.1%
    • Catalyst: Athough Aurora is a Canadian Licensed Producer (LP) it has strategic interests in the U.S. and the failure of the DEA to provide a timeline for cannabis rescheduling rattled investor confidence.
  3. Canopy Growth (CGC): DOWN 6.4%
    • Catalyst: After the market closed on July 28, Canopy revealed plans to sell additional shares in both the U.S. and Canada at market prices which spooked investors, as it signaled potential dilution and raised concerns about the company’s cash position.
  4. Organigram Global (OGI): DOWN 5.4%
    • Catalyst: In addition to being swept up in the overall cannabis market downturn Organigram’s trading volume on July 29th declined 71% from its average, suggesting weak demand and limited buying support.
  5. Cronos Group (CRON): DOWN 2.4%
    • Catalyst: Cronos' modest decline may suggest that some investors are waiting on the sidelines for clearer guidance in the upcoming Q2 earnings report scheduled for August 7.


Summary

The above 5 constituents in the Canadian Cannabis LP Stocks Portfolio declined 6.5% yesterday.


More By This Author:

6 Largest Cannabis MSOs Dropped By 6.9%, On Average, On Tuesday, July 29th - Here's Why
Cannabis MSOs Were Up Dramatically Week Ending July 25 - Here's Why
3 Of 8 Largest Integrated Semiconductor Manufacturers Crashed 11%, On Average, Yesterday - Here's Why

This article has been composed with the exclusive application of the human intelligence (HI) of the author. No artificial intelligence (AI) technology has been deployed. 

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with
Weed Investor 3 months ago Member's comment
$TLRY tanked because of a non-cash impairment item? Literally just accounting and has zero effect on the business itself. Bullish on #Tilray
Cannabis Stock Buyer 3 months ago Member's comment
over 2.5 billion total (without impairment would have just been normal 1 billion yearly loss).
Weed Investor 3 months ago Member's comment
What? No. Their net loss was $2.181bn with $2.096bn in impairments for the year. $85m net loss for the year excluding impairments.
Stock Picks 3 months ago Member's comment
Lorimer, what do you say about the above?